Issues with reporting and interpretation of Khan et al. 2021.

DeVito, Nicholas J; Drysdale, Henry

DeVito, Nicholas J; Drysdale, Henry.

Afiliação

DeVito NJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, England. nicholas.devito@phc.ox.ac.uk.
Drysdale H; Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, England.

BMC Infect Dis ; 22(1): 567, 2022 Jun 22.

Article em En | MEDLINE | ID: mdl-35733097

ABSTRACT

ABSTRACT

A recent publication in BMC Infectious Diseases concerning the use of convalescent plasma for the treatment of COVID-19 had a number of major issues. This correspondence details specific instances of unclear reporting as well as major omissions when discussing the context of the trial. These render the study's findings and conclusions misleading.

Assuntos

COVID-19; COVID-19/terapia; Humanos; Imunização Passiva; Soroterapia para COVID-19

Palavras-chave

Convalescent Plasma; Covid-19; Trial Registration; Trial Reporting; Trials Transparency

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google